Kirchberger, M.C.; Gfesser, M.; Erdmann, M.; Schliep, S.; Berking, C.; Heppt, M.V.
Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study. J. Clin. Med. 2023, 12, 4837.
https://doi.org/10.3390/jcm12144837
AMA Style
Kirchberger MC, Gfesser M, Erdmann M, Schliep S, Berking C, Heppt MV.
Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study. Journal of Clinical Medicine. 2023; 12(14):4837.
https://doi.org/10.3390/jcm12144837
Chicago/Turabian Style
Kirchberger, Michael Constantin, Michael Gfesser, Michael Erdmann, Stefan Schliep, Carola Berking, and Markus Vincent Heppt.
2023. "Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study" Journal of Clinical Medicine 12, no. 14: 4837.
https://doi.org/10.3390/jcm12144837
APA Style
Kirchberger, M. C., Gfesser, M., Erdmann, M., Schliep, S., Berking, C., & Heppt, M. V.
(2023). Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study. Journal of Clinical Medicine, 12(14), 4837.
https://doi.org/10.3390/jcm12144837
